American Healthcare REIT, Inc. (AHR) Stock Forecast
Data as of Sep 16, 2026Real Estate · Current price $53.70 (+1.02%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 12, 2026 | Michael Lewis | Truist Financial | $57.00 | +6.1% |
| Jan 29, 2026 | Juan Sanabria | BMO Capital | $55.00 | +2.4% |
| Jan 20, 2026 | Michael Lewis | Truist Financial | $52.00 | -3.2% |
| Nov 17, 2025 | Ronald Kamdem | Morgan Stanley | $52.00 | -3.2% |
| Aug 26, 2025 | Michael Lewis | Truist Financial | $46.00 | -14.3% |
| Aug 13, 2025 | Michael Carroll | RBC Capital | $45.00 | -16.2% |
| Apr 28, 2025 | Joe Dickstein | Jefferies | $37.00 | -31.1% |
| Nov 15, 2024 | Michael Lewis | Truist Financial | $29.00 | -46.0% |
| Sep 20, 2024 | Michael Lewis | Truist Financial | $27.00 | -49.7% |
| Sep 20, 2024 | Austin Wurschmidt | KeyBanc | $28.00 | -47.9% |
| Sep 16, 2024 | Austin Wurschmidt | KeyBanc | $27.00 | -49.7% |
| Sep 3, 2024 | Michael Lewis | Truist Financial | $22.00 | -59.0% |
| Jun 28, 2024 | Michael Lewis | Truist Financial | $17.00 | -68.3% |
| Apr 3, 2024 | Michael Lewis | Truist Financial | $16.00 | -70.2% |
Top Analysts Covering AHR
AHR vs Sector & Market
| Metric | AHR | Real Estate Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.61 | 2.42 |
| Analyst Count | 13 | 9 | 18 |
| Target Upside | +19.9% | +47.5% | +19.5% |
| P/E Ratio | 130.48 | 26.30 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.50B | $2.71B | $3.03B | 3 |
| 2027-12-31 | $2.79B | $3.03B | $3.39B | 4 |
| 2028-12-31 | $2.84B | $3.08B | $3.44B | 1 |
| 2029-03-31 | $611M | $702M | $917M | 2 |
| 2029-06-30 | $616M | $708M | $925M | 2 |
| 2029-09-30 | $622M | $715M | $934M | 2 |
| 2029-12-31 | $627M | $721M | $942M | 2 |
| 2030-03-31 | $628M | $722M | $943M | 2 |
| 2030-06-30 | $639M | $734M | $959M | 2 |
| 2030-09-30 | $646M | $742M | $969M | 2 |
| 2030-12-31 | $648M | $745M | $972M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.72 | $0.75 | $0.77 | 3 |
| 2027-12-31 | $0.94 | $0.98 | $1.01 | 3 |
| 2028-12-31 | $1.08 | $1.20 | $1.38 | 1 |
| 2029-03-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2029-06-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2029-09-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2030-03-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2030-06-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2030-09-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for AHR?
The consensus among 13 analysts covering American Healthcare REIT, Inc. (AHR) is Buy with an average price target of $57.20.
What is the highest price target for AHR?
The highest price target for AHR is $57.00, set by Michael Lewis at Truist Financial on 2026-03-12.
What is the lowest price target for AHR?
The lowest price target for AHR is $16.00, set by Michael Lewis at Truist Financial on 2024-04-03.
How many analysts cover AHR?
13 analysts have issued ratings for American Healthcare REIT, Inc. in the past 12 months.
Is AHR a buy or sell right now?
Based on 13 analyst ratings, AHR has a consensus rating of Buy (2.00/5) with a +19.9% upside to the consensus target of $57.20.
What are the earnings estimates for AHR?
Analysts estimate AHR will report EPS of $0.75 for the period ending 2026-12-31, with revenue estimated at $2.71B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.